Skip Navigation

Cardiovascular Research 2003 59(1):152-159; doi:10.1016/S0008-6363(03)00323-7
© 2003 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by O'Kane, P. D.
Right arrow Articles by Ferro, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by O'Kane, P. D.
Right arrow Articles by Ferro, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2003, European Society of Cardiology

Aspirin modifies nitric oxide synthase activity in platelets: effects of acute versus chronic aspirin treatment

Peter D. O'Kanea,b, Lindsay R. Queenb, Yong Jib, Vikash Reebyeb, Paula Strattonb, Graham Jacksona and Albert Ferrob,*

aDepartment of Cardiology, Cardiothoracic Centre, St Thomas’ Hospital, London, UK
bDepartment of Clinical Pharmacology, Centre for Cardiovascular Biology and Medicine, King's College London, St Thomas’ Hospital, Lambeth Palace Road, London SE1 7EH, UK

* Corresponding author. Tel.: +44-20-7928-9292x2350; fax: +44-20-7401-2242. albert.ferro{at}kcl.ac.uk

Objective: We examined the effects of aspirin on basal and β-adrenoceptor (β-AR)-mediated nitric oxide synthase (NOS) activity in normal platelets. Methods: NOS activity was determined from the conversion of L-[3H]arginine to L-[3H]citrulline, both basally and following β-AR stimulation, in platelets from healthy human subjects following both short- and long-term aspirin administration. Results: Basal L-[3H]citrulline increased following aspirin 800 mg administered intravenously in vivo, from 0.31±0.12 to 0.76±0.14 pmol/108 platelets (P<0.01). Isoproterenol at 1 µmol/l increased platelet NOS activity before but not following intravenous aspirin. After short-term in vitro treatment with aspirin 10 µmol/l, 400 µmol/l or 4 mmol/l, basal platelet L-[3H]citrulline increased similarly, an effect not seen with indomethacin 100 µmol/l or ibuprofen 10 µmol/l. Platelet NOS activity was not increased by albuterol 1 µmol/l, in the presence of indomethacin, ibuprofen or aspirin in vitro. By contrast, oral aspirin 75 mg daily for 14 days did not affect basal platelet NOS activity, but abolished β-adrenergic NOS activation. Conclusions: Aspirin activates basal platelet NOS acutely, but not chronically, through a mechanism independent of cyclooxygenase (COX) inhibition. By contrast, both short- and long-term aspirin treatment inhibit platelet β-adrenergic NOS activation by a COX-dependent mechanism. This indicates that aspirin exerts divergent effects on basal and β-AR-stimulated platelet NOS activity, which are likely to be of clinical relevance.

KEYWORDS Adrenergic; Anticoagulants; Nitric oxide; Platelets; Vasoactive agents


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
P. Rousseau, M. Tartas, B. Fromy, A. Godon, M.-A. Custaud, J. L. Saumet, and P. Abraham
Platelet inhibition by low-dose aspirin but not by clopidogrel reduces the axon-reflex current-induced vasodilation in humans
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2008; 294(5): R1420 - R1426.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.